BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21323741)

  • 41. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
    Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
    Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
    Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
    Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene mutation analysis and immunohistochemical study of beta-catenin in odontogenic tumors.
    Miyake T; Tanaka Y; Kato K; Tanaka M; Sato Y; Ijiri R; Inayama Y; Ito Y; Aoki S; Kawabe R; Tohnai I
    Pathol Int; 2006 Dec; 56(12):732-7. PubMed ID: 17096730
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CTNNB1 (beta-catenin) mutation is rare in brain tumours but involved as a sporadic event in a brain metastasis.
    Lee CI; Hsu MY; Chou CH; Wang C; Lo YS; Loh JK; Howng SL; Hong YR
    Acta Neurochir (Wien); 2009 Sep; 151(9):1107-11. PubMed ID: 19582367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
    Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
    Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
    Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K
    Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas.
    Palacios J; Gamallo C
    Cancer Res; 1998 Apr; 58(7):1344-7. PubMed ID: 9537226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
    Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
    Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
    Chen S; Liu J; Li G; Mo F; Xu X; Zhang T; Zhang X; Li J; Han X; Sun Y
    Scand J Gastroenterol; 2008; 43(4):456-64. PubMed ID: 18365911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
    Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
    Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis.
    Garcia-Rostan G; Camp RL; Herrero A; Carcangiu ML; Rimm DL; Tallini G
    Am J Pathol; 2001 Mar; 158(3):987-96. PubMed ID: 11238046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nuclear translocation of beta-catenin protein but absence of beta-catenin and APC mutation in gastrointestinal carcinoid tumor.
    Su MC; Wang CC; Chen CC; Hu RH; Wang TH; Kao HL; Jeng YM; Yuan RH
    Ann Surg Oncol; 2006 Dec; 13(12):1604-9. PubMed ID: 17009161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistochemical distribution of CD9 in parotid gland tumors.
    Sakamoto K; Nakamura Y; Nakashima T
    Auris Nasus Larynx; 2004 Mar; 31(1):49-55. PubMed ID: 15041054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutations in exon 3 of the CTNNB1 gene (beta-catenin gene) in cutaneous adnexal tumors.
    Kazakov DV; Sima R; Vanecek T; Kutzner H; Palmedo G; Kacerovska D; Grossmann P; Michal M
    Am J Dermatopathol; 2009 May; 31(3):248-55. PubMed ID: 19384065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistological features in adenomatoid odontogenic tumor: review of the literature and first expression and mutational analysis of β-catenin in this unusual lesion of the jaws.
    Harnet JC; Pedeutour F; Raybaud H; Ambrosetti D; Fabas T; Lombardi T
    J Oral Maxillofac Surg; 2013 Apr; 71(4):706-13. PubMed ID: 23265580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequent nuclear accumulation of beta-catenin in pituitary adenoma.
    Semba S; Han SY; Ikeda H; Horii A
    Cancer; 2001 Jan; 91(1):42-8. PubMed ID: 11148558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.
    Lazar AJ; Tuvin D; Hajibashi S; Habeeb S; Bolshakov S; Mayordomo-Aranda E; Warneke CL; Lopez-Terrada D; Pollock RE; Lev D
    Am J Pathol; 2008 Nov; 173(5):1518-27. PubMed ID: 18832571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes.
    Skálová A; Vanecek T; Majewska H; Laco J; Grossmann P; Simpson RH; Hauer L; Andrle P; Hosticka L; Branžovský J; Michal M
    Am J Surg Pathol; 2014 Jan; 38(1):23-33. PubMed ID: 24145651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The different pathogeneses of sporadic adenoma and adenocarcinoma in non-ampullary lesions of the proximal and distal duodenum.
    Niwa A; Kuwano S; Tomita H; Kimura K; Orihara Y; Kanayama T; Noguchi K; Hisamatsu K; Nakashima T; Hatano Y; Hirata A; Miyazaki T; Kaneko K; Tanaka T; Hara A
    Oncotarget; 2017 Jun; 8(25):41078-41090. PubMed ID: 28467793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of the CTNNB1 mutation genotype in surgically resected fibromatosis of the breast.
    Kim T; Jung EA; Song JY; Roh JH; Choi JS; Kwon JE; Kang SY; Cho EY; Shin JH; Nam SJ; Yang JH; Choi YL
    Histopathology; 2012 Jan; 60(2):347-56. PubMed ID: 22211293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.